Skip to main content
BIO-GENE TECHNOLOGY LTD logo

BIO-GENE TECHNOLOGY LTD — Investor Relations & Filings

Ticker · BGT ISIN · AU000000BGT8 ASX Professional, scientific and technical activities
Open in API
Filings indexed 456 across all filing types
Latest filing 2026-05-25 Investor Presentation
Country AU Australia
Listing ASX BGT

About BIO-GENE TECHNOLOGY LTD

https://bio-gene.com.au/

Bio-Gene Technology Ltd is a technology company focused on the development and commercialization of novel insecticides derived from naturally occurring chemistry. The company addresses the global challenge of insecticide resistance through its proprietary platform based on beta-triketone chemistry. Its primary product candidates include Flavocide, a nature-identical version of a compound found in specific eucalyptus species, and Qcide, a natural oil extract. These solutions are designed for diverse applications, including crop protection, grain storage, public health, and animal health. By utilizing a unique mode of action, the company provides alternatives to traditional chemical pesticides, aiming to deliver effective pest management with a favorable safety profile for non-target organisms and the environment.

Recent filings

Filing Released Lang Actions
Investor Presentation - Placement 20 pages 2.7MB
Investor Presentation Classification · 95% confidence The document is a slide deck titled “Investor Presentation” with corporate strategy, market analysis, product pipeline, and financial highlights aimed at investors. It does not present audited financial statements or regulatory disclosures but is a detailed presentation for investors, matching the Investor Presentation category.
2026-05-25 English
Proposed issue of securities - BGT 6 pages 22.3KB
Share Issue/Capital Change Classification · 93% confidence The document is an ASX Appendix 3B announcement detailing a proposed placement and issue of securities, including the number of shares, options, issue price, conditions, timetables, and listing rule compliance. This is clearly a notification of a new share issue/capital change rather than a full financial report, earnings release, or management presentation. It falls squarely under Share Issue/Capital Change.
2026-05-25 English
Proposed issue of securities - BGT 8 pages 26.7KB
Share Issue/Capital Change Classification · 91% confidence The document is an ASX Appendix 3B announcement detailing a proposed issue of securities under a securities purchase plan, including number of shares and attaching options, pricing, timetable and conditions. It is not a financial report, earnings release, proxy or management discussion; rather it is an announcement of a new share issue/fundraising under ASX listing rules. This fits the “Share Issue/Capital Change” category.
2026-05-25 English
Results of Placement 4 pages 161.9KB
Capital/Financing Update Classification · 95% confidence The document is an ASX market announcement detailing a capital raising via a Placement and partly underwritten Share Purchase Plan, including issue prices, tranche details, use of proceeds, timetable, and underwriting arrangements. It is clearly a fundraising/capital structure update and not a full financial report or other category.
2026-05-25 English
Trading Halt 2 pages 643.4KB
Regulatory Filings Classification · 85% confidence The document is an ASX market announcement requesting a trading halt under Listing Rule 17.1 pending a proposed capital raising. It is a regulatory compliance notice rather than substantive report content on financial results or a formal financing update. It fits the fallback category for general regulatory announcements and compliance filings.
2026-05-21 English
BGT to expand Flavocide and Qcide evaluation to Asia 3 pages 603.4KB
Regulatory Filings Classification · 85% confidence The document is an ASX announcement detailing Bio-Gene’s expansion of product evaluation (vector control testing) in Asia. It contains no financial results, no meeting materials, no fundraising, no legal or governance specifics—it is a corporate update filed for regulatory compliance. It does not include substantive financial statements or executive changes. Therefore it falls under the general “Regulatory Filings” category as a miscellaneous announcement.
2026-05-20 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.